Contract for the supply of aCGH slides and associated Analyser

Official notice

Authority: The Newcastle Upon Tyne Hospitals NHS Foundation Trust (Central government)

GoodsAward procedure without prior publication of a call for competition

Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC22)

Awarded value£1,069,985published contract · exc. VAT

Awarded 24 Feb 2021no call for competition

Awarded to Illumina Cambridge Ltd

What is being bought

Published requirement description

Contract for the supply of aCGH slides and associated Analyser with maintenance and support included for a period of 24 months with the option to extend for a further 2 x 12 months

CPV: Laboratory reagents

The lotProcurement structure

single lot · no lot value published

Lot #1

Delivery: North East · Tyneside

Procedure terms & legal framework

From the official record · publisher note attached

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0025 Utilities Contracts Regulations 2016 (Directive 2014/25/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 25 Feb 2021, 16:32 GMT
Last source update: 25 Feb 2021, 16:32 GMT
Authority reference: T/2021/007
FTS notice number: 2021/S 000-003840
Classification (CPV): Laboratory reagents
Delivery area: North East (UKC22)
Official registry OCID: ocds-h6vhtk-029668 Find a Tender

Why no open competition: The procurement falls outside the scope of application of the directive
Published justification: Characteristic patterns of DNA methylation of CpG islands in the genome are key features in various paediatric and adult solid tumours.
The Illumina iScan is the only scanning platform which allows genome-wide methylation studies using the Infinium Methylation EPIC BeadChip.
The Illumina 850k EPIC array assesses the DNA methylation status of a small proportion of the 850,000 individual CpG sites on the array.
Illumina 850k CytoSNP BeadChips require use of either NextSeq 500/550 or iScan scanners – no other scanners will work with the BeadChips
An algorithm, developed at the DKFZ in Heidelberg, Germany, is able to distinguish brain tumour entities based on their methylation profile using this platform (Capper et al. Nature. 2018 March 22; 555(7697): 469–474).
This internationally recognised classifier is necessary to deliver accurate diagnosis for paediatric and adult tumours within the Yorkshire and North East GLH region through the new National Genomic Test Directory.

Publisher note: To view this notice, please click here: https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=573609084 GO Reference: GO-2021225-PRO-17843462

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £1,069,9851 contract exc. VAT

Contracts signed 1latest 24 Feb 2021

Awarded to	Value	Date	Status
Illumina Cambridge Ltd	£1,069,985 †	—	Awarded

Contracts

Contract for the supply of aCGH slides and associated Analyser · Illumina Cambridge Ltd
Signed
24 Feb 2021
Value
£1,069,985
Status
active

Contracting authority & participating public bodies

The Newcastle upon Tyne Hospitals NHS Foundation Trust

Contracting authorityCentral GovernmentGenetics diagnostic activities Regent Point, Regent Farm Road, Newcastle upon Tyne, North East, NE3 3HDContact name, email, phone

Bidders & participating suppliers

1 commercial party on the notice

ILLUMINA CAMBRIDGE LIMITEDAwarded supplier03625145 19 Granta Park, Great Abington, Cambridge, North East, CB216DFContact email, phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.